Method and apparatus for categorizing breast density and assessing cancer risk utilizing acoustic parameters

1. A method, comprising:

transmitting an acoustic signal through a breast tissue volume;

measuring, throughout the breast tissue volume, a distribution of one or more acoustic parameters comprising sound speed based upon an analysis of the acoustic signal transmitted through the breast tissue volume;

obtaining an average whole breast sound speed velocity based upon at least a measured distribution of sound speed; and

quantifying present or future cancer risk based upon a comparison between the average whole breast sound speed velocity and one or more of the following BI-RADS breast density measures:

a fatty BI-RADS: 1 categorization if the average whole breast sound speed velocity is substantially between 1400-1415 m/s;

a scattered BI-RADS: 2 categorization if the average whole breast sound speed velocity is substantially between 1405-1420 m/s;

a heterogeneous BI-RADS: 3 categorization if the average whole breast sound speed velocity is substantially between 1420-1465 m/s; and

a dense BI-RADS: 4 categorization if the average whole breast sound speed velocity is substantially between 1460-1575 m/s.

2. The method according to claim 1 , further comprising: utilizing a tissue volume separator to conduct the measuring step, wherein the tissue volume separator further conducts the step of segmenting data for conducting the measuring step.

3. The method according to claim 2 , wherein obtaining an average whole breast sound speed velocity comprises dividing a segmented volume of the breast tissue volume, segmented based on an acoustic parameter of the one or more acoustic parameters, by a total breast volume.

4. The method according to claim 3 , wherein segmenting data comprises dividing a volume of tissue having a sound speed exceeding a sound speed threshold value by the total breast volume.

5. The method according to claim 1 , wherein the one or more acoustic parameters comprise attenuation.

6. The method according to claim 1 , wherein obtaining an average whole breast sound speed velocity comprises obtaining a statistical measure of central tendency.

7. The method according to claim 6 , wherein the statistical measure of central tendency comprises a mean, mode, median, range, or standard deviation of one or more of sound speed and attenuation obtained from analyzing the acoustic signal.

8. The method according to claim 1 , wherein the acoustic signal comprises a sequential series of waves.

9. The method according to claim 1 , wherein the acoustic signal comprises a sequential series of pulses.

10. The method according to claim 1 , wherein obtaining the average whole breast sound speed velocity further comprises:

developing at least one average sound speed histogram arising from the measured distribution of sound speed; and

obtaining the average whole breast sound speed velocity based on the at least one average sound speed histogram.

11. A method, comprising the steps of:

transmitting an acoustic signal through a volume of biological tissue;

measuring, throughout the volume of biological tissue, a distribution of at least one acoustic parameter comprising one or more of sound speed and attenuation by analyzing the acoustic signal transmitted through the volume of biological tissue;

obtaining an average sound speed velocity measure of the volume of biological tissue based upon the measured sound speed; and

quantifying present or future cancer risk based upon a comparison between the average sound speed velocity measure and one or more of the following BI-RADS breast density measures:

a fatty BI-RADS: 1 categorization if the average sound speed velocity measure is substantially between 1400-1415 m/s;

a scattered BI-RADS: 2 categorization if the average sound speed velocity measure is substantially between 1405-1420 m/s;

a heterogeneous BI-RADS: 3 categorization if the average sound speed velocity measure is substantially between 1420-1465 m/s; and

a dense BI-RADS: 4 categorization if the average sound speed velocity measure is substantially between 1460-1575 m/s.

12. The method according to claim 11 , wherein the quantifying step is conducted without obtaining a measure of biological tissue density.

13. The method according to claim 12 , further comprising: applying one or more of an age, menopausal status, age at menarche, parity, age at first birth, number of first and second degrees relatives with breast cancer, prior breast biopsies, hormonal usage, history of atypical hyperplasia, or history of lobular carcinoma in situ of a host subject of the biological tissue with the obtained measure to further refine the quantifying step.

14. The method according to claim 12 , wherein the biological tissue is breast tissue.

15. The method according to claim 12 , wherein the biological tissue is organ tissue, wherein the organ tissue is liver tissue.

16. The method according to claim 11 , wherein the obtained measure of the biological tissue is a statistical measure of central tendency used for assessing density of the biological tissue.

17. The method according to claim 16 , further comprising: applying one or more of an age, menopausal status, age at menarche, parity, age at first birth, number of first and second degrees relatives with breast cancer, prior breast biopsies, hormonal usage, history of atypical hyperplasia, or history of lobular carcinoma in situ of a host subject of the biological tissue with the obtained measure to further refine the quantifying step.

18. The method according to claim 11 , wherein the biological tissue is breast tissue.

19. The method according to claim 11 , wherein the biological tissue is any organ tissue.

20. The method according to claim 11 , wherein obtaining the average sound speed velocity measure further comprises:

developing at least one average sound speed histogram arising from the measured sound speed; and

obtaining the average whole breast sound speed velocity based on the at least one average sound speed histogram.

21. An apparatus, comprising:

a non-ionizing apparatus located proximate breast tissue, wherein the non-ionizing apparatus comprises a transducer configured to expose the breast tissue to an acoustic signal by transmitting the acoustic signal through the breast tissue;

a tissue volume separator coupled to the non-ionizing apparatus, wherein the tissue volume separator is configured to measure a distribution of one or more acoustic parameters comprising sound speed based upon an analysis of the acoustic signal;

a first module configured to obtain an average whole breast sound speed velocity based on the measured distribution of sound speed; and

a second module configured to quantify present of future cancer risk based upon a comparison between the average whole breast sound speed velocity and one or more of the following BI-RADS breast density measures:

a fatty BI-RADS: 1 categorization if the average whole breast sound speed velocity is substantially between 1400-1415 m/s;

a scattered BI-RADS: 2 categorization if the average whole breast sound speed velocity is substantially between 1405-1420 m/s;

a heterogeneous BI-RADS: 3 categorization if the average whole breast sound speed velocity is substantially between 1420-1465 m/s; and

a dense BI-RADS: 4 categorization if the average whole breast sound speed velocity is substantially between 1460-1575 m/s.

22. The apparatus according to claim 21 , wherein the non-ionizing apparatus comprises:

a platform disposed substantially adjacent a tank, wherein the tank includes a fluid;

means for inserting the breast tissue into the tank and proximate to the transducer;

wherein the transducer is configured to transmit the acoustic signal through the breast tissue for receipt at the tissue volume separator.

23. The apparatus according to claim 21 , wherein a coupling fluid is disposed upon the breast tissue, wherein the non-ionizing apparatus comprises:

an ultrasound caliper disposed upon the coupling fluid and proximate to the breast tissue, wherein the ultrasound caliper comprises

means for imparting the acoustic signal to the breast tissue for receipt at the tissue volume separator.

24. The apparatus according to claim 21 , wherein the tissue volume separator comprises:

an imaging device; and

a waveform generator,

a digital-to-analog converter connected to the waveform generator,

an acoustic transmit amplifier connected to the digital-to-analog converter,

wherein the acoustic transmit amplifier is connected to a transmitter end of the imaging device,

a receive amplifier, wherein the receive amplifier is connected to a receiver end of the imaging device,

an analog-to-digital converter connected to the receive amplifier, and

a value generator connected to the analog-to-digital converter.

25. The apparatus according to claim 24 , wherein the imaging device is an ultrasound tomography device defined, at least in part, by a transducer ring.

26. A method, comprising:

transmitting an acoustic signal through a volume of biological tissue;

measuring, throughout the volume of biological tissue, a distribution of at least one acoustic parameter including one or more of sound speed and attenuation by analyzing the transmitted acoustic signal; and

quantifying present or future cancer risk by associating an average whole breast sound speed velocity with one or more of the following BI-RADS breast density measures:

a fatty BI-RADS: 1 categorization if the average whole breast sound speed velocity ranges between approximately about 1400-1415 m/s;

a scattered BI-RADS: 2 categorization if the average whole breast sound speed velocity ranges between approximately about 1405-1420 m/s;

a heterogeneous BI-RADS: 3 categorization if the average whole breast sound speed velocity ranges between approximately about 1420-1465 m/s; and

a dense BI-RADS: 4 categorization if the average whole breast sound speed velocity ranges between approximately about 1460-1575 m/s.